Cairo hosts the 7th MASH Hematology Summit and 2nd Elite Ovarian Cancer Conference
The 7th edition of the MASH Hematology Summit and the 2nd Elite Conference on Integrated Ovarian Cancer Care took place in Cairo, gathering leading specialists from Egypt, the Middle East, Russia and beyond. The events were reported on 9 November 2026 and targeted hematology and oncology professionals.
In this story
At a glance
- What changes
- Two major scientific meetings were convened in Cairo
- Timing
- Reported on 9 November 2026
- Who is affected
- Hematology and ovarian‑cancer specialists, researchers and industry partners
The details
Event Overview
Cairo hosted two high‑profile scientific gatherings: the 7th MASH Hematology Summit, organized by the Egyptian Society of Hematology and Bone Marrow Transplantation with support from AbbVie, and the 2nd Elite Conference on Integrated Ovarian Cancer Care, sponsored by the Egyptian Cancer Society. Both events featured international speakers and attracted experts from Egypt, Saudi Arabia, the United Arab Emirates, Russia and other countries.
Program Highlights
The MASH Summit focused on advances in treating malignant hematologic diseases, including large‑cell B‑cell lymphoma, follicular lymphoma, and marginal zone lymphoma. Sessions covered emerging therapies that move beyond conventional chemo‑immunotherapy, MRD measurement, and circulating tumor DNA. Interactive workshops presented the latest clinical evidence and therapeutic options.
The Elite Conference addressed integrated care for ovarian cancer, emphasizing precision medicine, resistance mechanisms, multidisciplinary collaboration, digital technologies and artificial intelligence. Speakers discussed improving diagnostic accuracy, tailoring treatment to molecular profiles, and supporting patients’ physical, psychological and social well‑being.
Industry Participation
AbbVie, a global biopharmaceutical company, played a key role in both meetings, showcasing its pipeline for hematologic and solid‑tumor indications. Company representatives highlighted ongoing research, evidence‑based practices and commitments to addressing unmet medical needs in the region.
Regional leaders, including Dr. Mohamed Haitham (AbbVie North Africa) and Dr. Alaa Fadil Alwan (Iraqi Hematology Society), emphasized the importance of continuous scientific dialogue to accelerate the translation of research into clinical practice.
What this means for travellers
Trip planning
- Travelers planning to attend future editions should monitor announcements from the Egyptian Society of Hematology and the Egyptian Cancer Society for dates and registration details.
- No changes to existing travel itineraries are required as the events have already concluded.
Cost and documents
- No new fees or documentation requirements were introduced for these specific meetings.
- Participants typically need a conference registration fee and a valid professional credential.
What you need to do
- Prospective attendees should check the official conference websites for registration deadlines.
- Medical professionals may need to provide proof of specialty or affiliation when registering.
Who this affects
-
Hematology specialists
The MASH Summit targeted clinicians and researchers in blood disorders and bone‑marrow transplantation.
What to do Review conference materials for updates on emerging therapies and diagnostic tools.
-
Ovarian cancer oncologists
The Elite Conference focused on integrated care and precision medicine for ovarian cancer patients.
What to do Consider incorporating discussed AI and digital tools into clinical workflows.
-
Pharmaceutical representatives
AbbVie and other industry partners presented their research programs at both events.
What to do Align product information with the scientific themes highlighted during the meetings.
Frequently asked questions
When were the MASH Hematology Summit and Elite Ovarian Cancer Conference held in Cairo?
Both meetings were reported on 9 November 2026, indicating they took place shortly before that date in Cairo.
Who organized the 7th MASH Hematology Summit?
The summit was organized by the Egyptian Society of Hematology and Bone Marrow Transplantation with sponsorship from AbbVie.
What topics were covered at the Elite Ovarian Cancer Conference?
The conference addressed integrated ovarian cancer care, precision medicine, resistance mechanisms, multidisciplinary collaboration, digital technologies and artificial intelligence.
Which companies supported the Cairo scientific meetings?
AbbVie, a global biopharmaceutical firm, supported both the MASH Summit and the Elite Conference.
How can I find information about future editions of these conferences?
Future announcements are expected from the Egyptian Society of Hematology and the Egyptian Cancer Society on their official websites and professional networks.
